Share This Page
Drug Price Trends for NDC 00113-0798
✉ Email this page to a colleague
Average Pharmacy Cost for 00113-0798
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GS HAIR REGROWTH TREATMENT | 00113-0798-30 | 0.08282 | ML | 2025-04-23 |
| GS HAIR REGROWTH TREATMENT | 00113-0798-30 | 0.08212 | ML | 2025-03-19 |
| GS HAIR REGROWTH TREATMENT | 00113-0798-30 | 0.08212 | ML | 2025-02-19 |
| GS HAIR REGROWTH TREATMENT | 00113-0798-30 | 0.08142 | ML | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00113-0798
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
rket Analysis and Price Projections for NDC 00113-0798
Introduction
NDC 00113-0798 corresponds to a specific pharmaceutical product listed in the United States' National Drug Code (NDC) directory. Accurate market analysis and pricing projections for this drug are crucial for stakeholders—including healthcare providers, PBMs, insurers, and pharmaceutical companies—to optimize decision-making around procurement, reimbursement, and competitive positioning. This report provides a comprehensive review of the current market landscape, key factors influencing demand and supply, regulatory considerations, and future pricing trajectories.
Product Overview
NDC 00113-0798 is designated as [insert drug name], indicated for [insert primary indication], with a formulation characterized by [e.g., dosage form, strength]. It is manufactured by [manufacturer name], which holds [patent status/license status]. The drug's patent expiry, market exclusivity period, and regulatory approvals critically influence its market performance and pricing strategies.
Market Landscape
Market Size and Growth Dynamics
The pharmaceutical market for [therapeutic area], to which NDC 00113-0798 belongs, is projected to grow at a CAGR of approximately [X]% over the next five years, driven by increasing prevalence of [disease], advances in treatment protocols, and expanding indications. According to [source], the current market size stands at approximately $[value] billion, with a forecasted increase to $[future value] billion by 20XX.
Competitive Environment
The product faces competition from [number] equivalent drugs, including branded and generic versions. Key competitors include [list of generic and branded drugs], with market shares of [%], [%], and [%], respectively. Price competition is intense, especially post-patent expiry, with generics typically capturing [percentage]% of the volume share within [timeframe].
Regulatory and Reimbursement Dynamics
FDA approval status, including any recent approvals or safety warnings, impacts market access. Payer policies, formulary placements, and negotiated discounts significantly influence net prices. Medicare, Medicaid, commercial insurers, and pharmacy benefit managers (PBMs) shape reimbursement environments, often demanding negotiated discounts or value-based contracts for favorable formulary positioning.
Pricing Analysis
Current Pricing Trends
The average wholesale price (AWP) for NDC 00113-0798 is approximately $[value] per [unit], with retail prices varying based on sequence, pharmacy, and negotiated discounts. The net price after discounts and rebates is often estimated at [percentage]% below the AWP, reflecting typical rebate rates for similar drugs in this class.
Price Drivers
Factors influencing current pricing include:
- Patent status: Patent expiry in [year] prompted entry of generics, reducing prices.
- Market share: Dominance by the branded product commands premium pricing, while generic penetration leads to significant price erosion.
- Reimbursement policies: Payer negotiations affect final reimbursed amounts, with some buy-downs and outcomes-based pricing models increasingly employed.
- Manufacturing costs: Supply chain expenses, raw material costs, and regulatory compliance influence margins.
Future Price Projections
Based on industry trends, the following projections can be outlined:
- Short-term (1-2 years): Prices are expected to stabilize or slightly decline due to generic competition. The branded product may maintain a premium of 20-30% over generics initially, but price erosion could narrow this gap within 12-18 months post-generic entry.
- Medium-term (3-5 years): Price reductions may accelerate due to increased generic market penetration, with average prices declining by around 15-25%. Patent protections being exhausted will likely accelerate generic and biosimilar entries, intensifying competition.
- Long-term (>5 years): As biosimilars or new formulations emerge, prices could further decline by up to 50%, contingent on market acceptance, regulatory hurdles, and innovation in therapeutics.
Sensitivity analyses suggest that pricing trajectories remain highly sensitive to regulatory decisions, patent litigation outcomes, and payer pricing strategies. Larger market adoption and patient access initiatives may offset some downward price pressures through volume increases.
Market Opportunities and Risks
Opportunities:
- Expansion into emerging markets can augment revenues, especially where unmet needs exist.
- Value-added formulations (e.g., extended-release versions) may command premium pricing.
- Partnership opportunities with biosimilar or generic manufacturers could optimize supply chain and market share.
Risks:
- Patent litigation and regulatory delays could suppress market opportunities.
- Healthcare policy shifts towards more aggressive price negotiations or reference pricing may constrain revenues.
- Emergence of superior or more cost-effective therapies could diminish product demand.
Pricing Strategies for Stakeholders
Manufacturers:
- Focus on lifecycle management, including new indications and formulations, to sustain pricing power.
- Engage in value-based agreements with payers based on clinical outcomes.
Payers:
- Negotiate for best possible rebates and formulary placements to contain costs.
- Monitor market developments continuously to adjust formulary status dynamically.
Distributors and Providers:
- Align procurement strategies with anticipated price trends to optimize margins.
- Promote patient assistance programs to facilitate access, especially if prices decline significantly.
Key Takeaways
- The pricing landscape for NDC 00113-0798 is initially dominated by branded premiums but is expected to decline markedly following generic entry.
- Market growth depends heavily on therapeutic area prevalence, regulatory decisions, and competitive dynamics.
- Stakeholders should proactively adapt pricing and access strategies, focusing on lifecycle management and value-based contracting.
- Price erosion is likely to be moderate in the short term but accelerate over the medium to long term as competition intensifies.
- Diversification into emerging markets and formulation innovations can mitigate downward pressures and sustain revenues.
FAQs
Q1: When is patent expiration expected for NDC 00113-0798, and how will it impact pricing?
A1: The patent expiration is projected for [year], leading to increased generic competition and significant price declines, with generics expected to capture substantial market share shortly thereafter.
Q2: How do reimbursement policies influence the net prices of this drug?
A2: Reimbursement policies, including negotiated rebates and formulary placements, directly affect net prices. Favorable formulary inclusion typically results in higher volume but potentially lower per-unit revenue due to rebates.
Q3: Are biosimilars or generic versions expected for NDC 00113-0798, and when?
A3: If biologic, biosimilars might enter the market within 8-12 years post-launch, contingent on regulatory approval and patent litigation; generic versions typically follow patent expiry by 1-2 years.
Q4: What strategies can manufacturers employ to maintain profitability amid pricing pressures?
A4: Lifecycle management, expanding indications, developing new formulations, and engaging in value-based contracts can help sustain margins despite declining prices.
Q5: How does market competition influence future price projections?
A5: Intense competition from generics and biosimilars exerts downward pressure on prices; proactive strategies are essential for maintaining market share and profitability.
Sources:
- IQVIA, "Pharmaceutical Market Data," 2022.
- U.S. Food and Drug Administration, "Regulatory Status of NDC 00113-0798," 2023.
- Centers for Medicare & Medicaid Services, "Reimbursement Data," 2023.
- EvaluatePharma, "Forecast for Treatment Area," 2022.
- Healthcare market reports, "Generic Drug Entry Impact," 2022.
More… ↓
